"
Team:Imperial College London/M2
From 2009.igem.org
(Difference between revisions)
(→Module 2 Contents) |
(→Module 2 Contents) |
||
| Line 39: | Line 39: | ||
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Genetic"><b>Genetic Circuit</b></a></center></td> | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Genetic"><b>Genetic Circuit</b></a></center></td> | ||
| - | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/Temporal_Control/M2/Wetlab/Results# | + | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/Temporal_Control/M2/Wetlab/Results#Module_2"><b>WetLab</b></a></center></td> |
<td width="20%"><center><a | <td width="20%"><center><a | ||
Revision as of 13:20, 9 October 2009
Module 2 - Encapsulsation
Overview
Aside from aiding in pill manufacture, encapsulation (Module 2) allows the safe passage of polypetides through the stomach into the intestine. The encapsulation process involves the production of a physical barrier, acid resistance proteins and the preservative trehalose. Without encapsulation, our polypeptides would be denatured and degraded by stomach acid and digestive proteases respectively.
About proteolysis.
Our solution represents a fusion between probiotic treatment & polypeptide encapsulation
